Day: July 18, 2022
Inclusion of Zai Lab shares in Shanghai-Hong Kong Stock Connect is effective todayZai Lab has been dual-primary listed on Nasdaq and the Hong Kong Stock Exchange, and its shares included in the Shenzhen-Hong Kong Stock Connect since June 2022
Zai Lab’s inclusion in two Stock Connect Programs provides additional opportunity for investors in mainland China to invest in the CompanySHANGHAI, SAN FRANCISCO, and CAMBRIDGE, Mass., July 17, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, announced, effective today, that its ordinary shares traded on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) are now included in the Shanghai-Hong Kong Stock Connect program. Similarly, Zai Lab’s ordinary shares traded...